SMART Health Cards: Terminology
0.1.0 - ci-build

SMART Health Cards: Terminology - Local Development build (v0.1.0). See the Directory of published versions

ValueSet: Immunization / All / CVX

Official URL: https://terminology.smarthealth.cards/ValueSet/immunization-all-cvx Version: 20230623
Draft as of 2023-07-06 Computable Name: ImmunizationAllCvxValueSet

Contains all CVX codes from https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx as of 2023-06-23.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

The following codes from the PH_VaccinesAdministeredCVX_CDC_NIP code system are included:

Code Description(s)
54 adenovirus, type 4
55 adenovirus, type 7
82 adenovirus, unspecified formulation
24 anthrax
19 BCG
27 botulinum antitoxin
26 cholera, unspecified formulation
29 CMVIG
56 dengue fever tetravalent
12 diphtheria antitoxin
28 DT (pediatric)
20 DTaP
106 DTaP, 5 pertussis antigens
107 DTaP, unspecified formulation
110 DTaP-Hep B-IPV
50 DTaP-Hib
120 DTaP-Hib-IPV
130 DTaP-IPV
1 DTP
22 DTP-Hib
102 DTP-Hib-Hep B
57 hantavirus
52 Hep A, adult
83 Hep A, ped/adol, 2 dose
84 Hep A, ped/adol, 3 dose
31 Hep A, pediatric, unspecified formulation
85 Hep A, unspecified formulation
104 Hep A-Hep B
30 HBIG
8 Hep B, adolescent or pediatric
42 Hep B, adolescent/high risk infant
43 Hep B, adult
44 Hep B, dialysis
45 Hep B, unspecified formulation
58 Hep C
59 Hep E
60 herpes simplex 2
46 Hib (PRP-D)
47 Hib (HbOC)
48 Hib (PRP-T)
49 Hib (PRP-OMP)
17 Hib, unspecified formulation
51 Hib-Hep B
61 HIV
118 HPV, bivalent
62 HPV, quadrivalent
86 IG
87 IGIV
14 IG, unspecified formulation
111 influenza, live, intranasal
15 influenza, split (incl. purified surface antigen)
16 influenza, whole
88 influenza, unspecified formulation
123 influenza, H5N1-1203
10 IPV
2 OPV
89 polio, unspecified formulation
39 Japanese encephalitis SC
63 Junin virus
64 leishmaniasis
65 leprosy
66 Lyme disease
3 MMR
4 M/R
94 MMRV
67 malaria
5 measles
68 melanoma
32 meningococcal MPSV4
103 meningococcal C conjugate
114 meningococcal MCV4P
108 meningococcal ACWY, unspecified formulation
7 mumps
69 parainfluenza-3
11 pertussis
23 plague
33 pneumococcal polysaccharide PPV23
100 pneumococcal conjugate PCV 7
109 pneumococcal, unspecified formulation
70 Q fever
18 rabies, intramuscular injection
40 rabies, intradermal injection
90 rabies, unspecified formulation
72 rheumatic fever
73 Rift Valley fever
34 RIG
119 rotavirus, monovalent
122 rotavirus, unspecified formulation
116 rotavirus, pentavalent
74 rotavirus, tetravalent
71 RSV-IGIV
93 RSV-MAb
6 rubella
38 rubella/mumps
76 Staphylococcus bacterio lysate
113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
9 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
115 Tdap
35 tetanus toxoid, adsorbed
112 tetanus toxoid, unspecified formulation
77 Tick-borne encephalitis vaccine (non-US)
13 TIG
95 TST-OT tine test
96 TST-PPD intradermal
97 TST-PPD tine test
98 TST, unspecified formulation
78 tularemia vaccine
91 typhoid, unspecified formulation
25 typhoid, oral
41 typhoid, parenteral
53 typhoid, parenteral, AKD (U.S. military)
101 typhoid, ViCPs
75 vaccinia (smallpox)
105 vaccinia (smallpox) diluted
79 vaccinia immune globulin
21 varicella
81 VEE, inactivated
80 VEE, live
92 VEE, unspecified formulation
36 VZIG
117 VZIG (IND)
37 yellow fever
121 zoster live
998 no vaccine administered
999 unknown
99 RESERVED - do not use
133 Pneumococcal conjugate PCV 13
134 Japanese Encephalitis IM
137 HPV, unspecified formulation
136 Meningococcal MCV4O
135 Influenza, high dose seasonal
131 typhus, historical
132 DTaP-IPV-HIB-HEP B, historical
128 Novel Influenza-H1N1-09, all formulations
125 Novel Influenza-H1N1-09, nasal
126 Novel influenza-H1N1-09, preservative-free
127 Novel influenza-H1N1-09
138 Td (adult)
139 Td(adult) unspecified formulation
140 Influenza, seasonal, injectable, preservative free
129 Japanese Encephalitis, unspecified formulation
141 Influenza, seasonal, injectable
142 tetanus toxoid, not adsorbed
143 Adenovirus types 4 and 7
144 influenza, seasonal, intradermal, preservative free
145 RSV-MAb (new)
146 DTaP,IPV,Hib,HepB
147 meningococcal MCV4, unspecified formulation
148 Meningococcal C/Y-HIB PRP
149 influenza, live, intranasal, quadrivalent
150 influenza, injectable, quadrivalent, preservative free
151 influenza nasal, unspecified formulation
152 Pneumococcal Conjugate, unspecified formulation
153 Influenza, injectable, MDCK, preservative free
154 Hep A, IG
155 influenza, recombinant, injectable, preservative free
156 Rho(D)-IG
157 Rho(D) -IG IM
158 influenza, injectable, quadrivalent
159 Rho(D) - Unspecified formulation
160 Influenza A monovalent (H5N1), ADJUVANTED-2013
801 AS03 Adjuvant
161 Influenza, injectable,quadrivalent, preservative free, pediatric
162 meningococcal B, recombinant
163 meningococcal B, OMV
164 meningococcal B, unspecified
165 HPV9
166 influenza, intradermal, quadrivalent, preservative free
167 meningococcal, unknown serogroups
168 influenza, trivalent, adjuvanted
169 Hep A, live attenuated
170 DTAP/IPV/HIB - non-US
171 Influenza, injectable, MDCK, preservative free, quadrivalent
172 cholera, WC-rBS
173 cholera, BivWC
174 cholera, live attenuated
175 Rabies - IM Diploid cell culture
176 Rabies - IM fibroblast culture
177 PCV10
178 OPV bivalent
179 OPV ,monovalent, unspecified
180 tetanus immune globulin
181 anthrax immune globulin
182 OPV, Unspecified
183 Yellow fever vaccine - alt
184 Yellow fever, unspecified formulation
185 influenza, recombinant, quadrivalent,injectable, preservative free
186 Influenza, injectable, MDCK, quadrivalent, preservative
187 zoster recombinant
188 zoster, unspecified formulation
189 HepB-CpG
190 Typhoid conjugate vaccine (TCV)
191 meningococcal A polysaccharide (non-US)
192 meningococcal AC polysaccharide (non-US)
193 Hep A-Hep B, pediatric/adolescent
194 Influenza, Southern Hemisphere
195 DT, IPV adsorbed
196 Td, adsorbed, preservative free, adult use, Lf unspecified
197 influenza, high-dose, quadrivalent
200 influenza, Southern Hemisphere, pediatric, preservative free
201 influenza, Southern Hemisphere, preservative free
202 influenza, Southern Hemisphere, quadrivalent, with preservative
198 DTP-hepB-Hib Pentavalent Non-US
203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
205 Influenza vaccine, quadrivalent, adjuvanted
206 Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
213 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
204 Ebola Zaire vaccine, live, recombinant, 1mL dose
214 Ebola, unspecified
211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
500 COVID-19 Non-US Vaccine, Product Unknown
501 COVID-19 IV Non-US Vaccine (QAZCOVID-IN)
502 COVID-19 IV Non-US Vaccine (COVAXIN)
503 COVID-19 LAV Non-US Vaccine (COVIVAC)
504 COVID-19 VVnr Non-US Vaccine (Sputnik Light)
505 COVID-19 VVnr Non-US Vaccine (Sputnik V)
506 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
507 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
508 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
509 COVID-19 PS Non-US Vaccine (EpiVacCorona)
510 COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
511 COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
220 HepB recombinant, 3-antigen, Al(OH)3
221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
222 Tick-borne encephalitis, unspecified
223 Tick-borne encephalitis, inactivated, PF, 0.25mL
224 Tick-borne encephalitis, inactivated, PF, 0.5mL
225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
226 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
512 SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
513 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
515 SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
517 SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
229 COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
301 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
300 COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
230 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
518 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
519 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
520 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
521 COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
231 influenza, Southern Hemisphere, high-dose, quadrivalent
303 RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
304 Respiratory syncytial virus (RSV), unspecified
302 COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose

 

Expansion

No Expansion for this valueset (not supported by Publication Tooling)

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code